PATENT CLAIM ANALYSIS

Application Number: 16116426
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "218100"]

Abstract:
In one embodiment, the present invention is a method of treating glioma and medulloblastoma brain tumors using the Zika virus and a tumor vaccine.

Claim (Index 19):
A method of treating GBM or medulloblastoma tumors, comprising the steps of\n (a) obtaining an anti-tumor composition comprising Zika virus, wherein the composition comprises carriers suitable for direct intra-tumoral delivery, (b) delivering the Zika virus composition to the tumor site, and (c) treating the patient with a tumor vaccine, wherein the tumor is treated.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15037774', '14254235', '16068826', '14416754', '09875349']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.683930893666798
- 35 USC 102 Novelty (BERT): 0.5238157249760058
- Combined Prediction Score: 0.6679193767977188
- Mean Citation Score: 270.50809200000003
- Max Citation Score: 309.7225
- Similarity Product: 217.8609528675676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test